NasdaqCM - Delayed Quote USD
TNF Pharmaceuticals, Inc. (TNFA)
At close: 4:00 PM EDT
Research Analysis
Earnings Per Share
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2018) | Next Qtr. (Jun 2018) | Current Year (2018) | Next Year (2019) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -921.6 | -- | -- |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2018) | Next Qtr. (Jun 2018) | Current Year (2018) | Next Year (2019) |
---|---|---|---|---|
No. of Analysts | -- | -- | 1 | -- |
Avg. Estimate | -- | -- | 11M | -- |
Low Estimate | -- | -- | 11M | -- |
High Estimate | -- | -- | 11M | -- |
Year Ago Sales | -- | -- | 3.93M | 11M |
Sales Growth (year/est) | -- | -- | 179.90% | -- |
Earnings History
CURRENCY IN USD | 6/30/2017 | 9/30/2017 | 12/31/2017 | |
---|---|---|---|---|
EPS Est. | -- | -460.8 | 0 | 691.2 |
EPS Actual | -- | -921.6 | -1,497.6 | -2,304 |
Difference | -- | -460.8 | -1,497.6 | -2,995.2 |
Surprise % | -- | -100.00% | -- | -433.30% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2018) | Next Qtr. (Jun 2018) | Current Year (2018) | Next Year (2019) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0.14 | 0 |
30 Days Ago | 0 | 0 | 0.14 | 0 |
60 Days Ago | 0 | 0 | 0.14 | 0 |
90 Days Ago | 0 | 0 | 0.14 | 0 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2018) | Next Qtr. (Jun 2018) | Current Year (2018) | Next Year (2019) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | TNFA | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -- | -- | -- | 4.50% |
Next Qtr. | -- | -- | -- | 9.60% |
Current Year | -- | -- | -- | 2.10% |
Next Year | -- | -- | -- | 12.90% |
Next 5 Years (per annum) | -- | -- | -- | 11.76% |
Past 5 Years (per annum) | -- | -- | -- | -- |
Related Tickers
SCNI Scinai Immunotherapeutics Ltd.
3.4500
-1.15%
THAR Tharimmune, Inc.
1.9500
-2.50%
XRTX XORTX Therapeutics Inc.
1.5500
0.00%
PHIO Phio Pharmaceuticals Corp.
2.9100
-3.64%
XBIO Xenetic Biosciences, Inc.
3.7950
+2.57%
SLRN Acelyrin, Inc.
5.97
0.00%
PULM Pulmatrix, Inc.
2.0199
+1.00%
ALTE.ST Alteco Medical AB
0.2100
0.00%
4XB.F XBiotech Inc.
6.55
+0.77%
VCNX Vaccinex, Inc.
3.3800
-0.29%